Skip to main content
. 2022 Mar 29;23(5):166. doi: 10.3892/ol.2022.13286

Figure 2.

Figure 2.

Distribution of CD155 expression (left), and receiver operating characteristic curve for prediction of recurrence (right). TPS, tumor proportion score; AUC, area under curve.